You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hormone Receptor Antagonists

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo

Recruiting
  • Hypertension
  • +8 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 22, 2022

Primary Aldosteronism Trial in Montréal (Renin measurements)

Not yet recruiting
  • Primary Aldosteronism
  • Renin measurements
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur de Montréal
Oct 30, 2023

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Renin Angiotensin Aldosterone System Genetic Polymorphism on

Recruiting
  • Myocardial Infarction
    • Cairo, Egypt
      Ain Shams University
    May 16, 2023

    Pediatric Cancer Trial in Yerevan (Ondansetron, Dexamethasone)

    Not yet recruiting
    • Pediatric Cancer
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    May 23, 2023

    Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical

    Not yet recruiting
    • Primary Hyperaldosteronism Due to Adrenal Adenoma
    • Unilateral adrenalectomy
    • Medical treatment (eplerenone)
    • Gothenburg, Sweden
    • +2 more
    Mar 30, 2023

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)

    Recruiting
    • Alcohol Use Disorder
    • Columbus, Ohio
      The Ohio State University
    Dec 11, 2022

    s to Learn More About Treatment With Steroidal Mineralocorticoid

    Active, not recruiting
    • Chronic Kidney Disease
    • +2 more
    • sMRA therapies
    • Whippany, New Jersey
      Many Locations
    Jan 30, 2023

    IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.

    Withdrawn
    • Critical Illness Sepsis, Severe
      • (no location specified)
      Jun 13, 2022

      IL-1ß and Its Receptor Antagonists in Treatment of Severe

      Withdrawn
      • Critical Illness
      • Sepsis, Severe
        • (no location specified)
        Jun 13, 2022

        Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

        Not yet recruiting
        • Advanced Solid Tumor
        • +8 more
        • (no location specified)
        Nov 13, 2023

        Interleukin 6 Receptor Antagonists in Corona Virus Disease 19

        Recruiting
        • Corona Virus Infection
        • ELISA
        • Assiut, Egypt
          AssiutU
        Feb 2, 2023

        CDK4/6 Inhibitors in Hormone Receptor-positive Advanced Breast

        Not yet recruiting
        • Breast Cancer
        • CDK4/6 inhibitor
        • Shanghai, Shanghai, China
          Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
        Apr 5, 2023

        Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)

        Not yet recruiting
        • Breast Neoplasms
        • Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
        • +2 more
        Oct 23, 2023

        Breast Cancer Trial in New Brunswick (U-13C-glucose)

        Not yet recruiting
        • Breast Cancer
        • New Brunswick, New Jersey
        • +1 more
        Feb 16, 2023

        Breast Cancer Trial (Trastuzumab Deruxtecan)

        Not yet recruiting
        • Breast Cancer
        • Trastuzumab Deruxtecan
        • (no location specified)
        Jul 10, 2023

        Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

        Recruiting
        • Hormone Receptor-positive Breast Cancer
        • Tampa, Florida
          Moffitt Cancer Center
        Dec 30, 2022

        Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

        Not yet recruiting
        • Hormone-receptor-positive Breast Cancer
        • +3 more
        • Aromatase inhibitor
        • +3 more
        • Guangzhou, Guangdong, China
          Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
        Apr 5, 2023

        HR Positive/HER2 Low Expression Metastatic Breast Cancer Trial in Guangzhou, Shantou, Qionghai (Disitamab vedotin, Endocrine

        Recruiting
        • HR Positive/HER2 Low Expression Metastatic Breast Cancer
        • Disitamab vedotin
        • Endocrine therapy
        • Guangzhou, Guangdong, China
        • +2 more
        Jun 19, 2023

        Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

        Active, not recruiting
        • Neuroendocrine Tumors
        • +2 more
        • Tampa, Florida
        • +1 more
        Jan 13, 2023

        Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

        Not yet recruiting
        • Prostate Adenocarcinoma
        • +2 more
        • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
        • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
        • Boston, Massachusetts
          Beth Israel Deaconess Medical Center
        Jan 4, 2023

        Acne Vulgaris Trial in Stanford (Clascoterone 1% Top Cream, Vehicle)

        Not yet recruiting
        • Acne Vulgaris
        • Stanford, California
          Stanford University
        Jun 6, 2023

        Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)

        Not yet recruiting
        • Metastatic Breast Cancer
        • Fulvestrant plus AI plus ribociclib
        • AI plus ribociclib
        • Seoul, Korea, Republic of
          Korea university Guro hospital
        Apr 16, 2023

        Heart Failure With Reduced Ejection Fraction Trial in New Haven (Best Practice Alert)

        Recruiting
        • Heart Failure With Reduced Ejection Fraction
        • Best Practice Alert
        • New Haven, Connecticut
          Cardiology/Internal Medicine Outpatient Clinics of Yale New Heal
        Jan 17, 2022